These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29520699)

  • 1. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
    Baumann S; Werner N; Ibrahim K; Westenfeld R; Al-Rashid F; Sinning JM; Westermann D; Schäfer A; Karatolios K; Bauer T; Becher T; Akin I
    Clin Res Cardiol; 2018 Aug; 107(8):653-657. PubMed ID: 29520699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
    Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.
    Becher T; Baumann S; Eder F; Perschka S; Loßnitzer D; Fastner C; Behnes M; Doesch C; Borggrefe M; Akin I
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):360-368. PubMed ID: 28660768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    Flaherty MP; Pant S; Patel SV; Kilgore T; Dassanayaka S; Loughran JH; Rawasia W; Dawn B; Cheng A; Bartoli CR
    Circ Res; 2017 Feb; 120(4):692-700. PubMed ID: 28073804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex High-Risk Indicated Percutaneous Coronary Intervention With Prophylactic Use of the Impella CP Ventricular Assist Device.
    van den Buijs DMF; van den Brink FS; Wilgenhof A; Zivelonghi C; Verouden N; Knaapen P; Sjauw KD; Vermeersch P; Nap A
    J Invasive Cardiol; 2022 Sep; 34(9):E665-E671. PubMed ID: 36001456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention.
    Reddy P; Merdler I; Zhang C; Cellamare M; Ben-Dor I; Bernardo NL; Hashim HD; Satler LF; Rogers T; Waksman R
    Am J Cardiol; 2024 Aug; 225():4-9. PubMed ID: 38871158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support.
    Iliodromitis KE; Kahlert P; Plicht B; Hoffmann AC; Eggebrecht H; Erbel R; Konorza TF
    Int J Cardiol; 2011 Nov; 153(1):59-63. PubMed ID: 20826017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.
    Meraj PM; Dixon S; Moses J; Ibrahim K; Schäfer A; Akin I; Hill J; Schreiber T; O'Neill WW
    J Interv Cardiol; 2019; 2019():9691753. PubMed ID: 31772553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention in patients refused from surgery: a different entity?
    Montone RA; Niccoli G
    Minerva Cardioangiol; 2018 Oct; 66(5):562-568. PubMed ID: 29527866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.